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Abstract
Introduction:  Worldwide,  hepatitis  B  virus,  hepatitis  C  virus,  and  human  immunodeﬁciency
virus are  major  health  problems.  Healthcare  workers  are  at  risk  of  transmitting  blood--borne
viruses,  and  surgeons  have  a  higher  risk  of  exposure  to  blood  and  higher  rates  of  percutaneous
injury than  other  healthcare  workers.  Septoplasty  is  among  the  3  most  commonly  performed
otolaryngological  surgeries  worldwide.
Objective:  To  determine  the  seroprevalence  of  Hepatitis  B  surface  antigen,  Hepatitis  C  virus
antibody, and  Human  Immunodeﬁciency  Virus  antibody  in  patients  undergoing  septoplasty  with
and without  turbinate  surgery  under  general  anesthesia,  and  to  determine  if  preoperative
testing should  be  performed  in  such  patients.
Methods:  This  retrospective  cross-sectional  study  included  3731  patients  that  underwent  septo-
plasty with  and  without  turbinate  surgery  between  January  2005  and  July  2015.  HBsAg,  anti-HCV,
and anti-HIV  seropositivity  in  the  patients  was  evaluated  retrospectively.
Results:  Mean  age  of  the  patients  was  36  years  (range:  11--81  years).  In  all,  117  (3.6%)  patients
were positive  for  HBsAg,  12  (0.3%)  were  positive  for  anti-HCV,  and  7  (0.2%)  were  positive  for
anti-HIV.
Conclusions:  Education  of  healthcare  workers  combined  with  routine  preoperative  serological
testing in  patients  undergoing  septoplasty  under  general  and  local  anesthesia  are  needed  to
increase awareness  of  hepatitis  B  and  C,  and  HIV  infection  among  healthcare  workers  and
patients in  order  to  decrease  the  transmission  rate.
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Soroprevalência  de  hepatite  B,  hepatite  C  e  vírus  da  imunodeﬁciência  humana  em
pacientes  submetidos  à  septoplastia
Resumo
Introduc¸ão:  No  mundo  todo,  o  vírus  da  hepatite  B  (VHB),  o  vírus  da  hepatite  C  (VHC)  e  o  vírus
da imunodeﬁciência  humana  (HIV)  são  problemas  de  saúde  importantes.  Os  proﬁssionais  de
saúde correm  o  risco  de  transmitir  vírus  transmitidos  pelo  sangue,  e  os  cirurgiões  têm  um  maior
risco de  exposic¸ão  ao  sangue  e  taxas  mais  elevadas  de  lesões  percutâneas  do  que  os  outros
proﬁssionais  de  saúde.  A  septoplastia  está  entre  as  três  cirurgias  otorrinolaringológicas  mais
comumente  realizadas  em  todo  o  mundo.
Objetivo:  Determinar  a  soroprevalência  de  anticorpos  HBsAg,  anti-HCV  e  anti-HIV  em  pacientes
submetidos  a  septoplastia  com  e  sem  cirurgia  de  concha  nasal  sob  anestesia  geral  e  determinar
se deve  ser  realizado  teste  pré-operatório  nesses  pacientes.
Método:  Este  estudo  transversal  retrospectivo  incluiu  3731  pacientes  que  foram  submetidos
à septoplastia  com  e  sem  cirurgia  de  concha  nasal  entre  janeiro  de  2005  e  julho  de  2015.  A
soropositividade  para  HBsAg,  anti-HCV  e  anti-HIV  nos  pacientes  foi  avaliada  retrospectivamente.
Resultados:  A  idade  média  dos  pacientes  foi  de  36  anos  (intervalo:  11-81  anos).  Ao  todo,  117
(3,6%) pacientes  foram  positivos  para  HBsAg,  12  (0,3%)  foram  positivos  para  anti-HCV  e  7  (0,2%)
positivos para  anti-HIV.
Conclusões:  A  educac¸ão  de  proﬁssionais  de  saúde  combinada  com  testes  sorológicos  rotineiros
pré-operatórios  em  pacientes  submetidos  a  septoplastia  sob  anestesia  geral  e  local  são
necessários  para  aumentar  a  conscientizac¸ão  sobre  a  hepatite  B  e  C  e  a  infecc¸ão  pelo  HIV
entre proﬁssionais  de  saúde  e  pacientes  para  diminuir  a  taxa  de  transmissão.
© 2016  Associac¸a˜o  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Ce´rvico-Facial.  Publicado
por Elsevier  Editora  Ltda.  Este e´  um  artigo  Open  Access  sob  uma  licenc¸a  CC  BY  (http://
creativecommons.org/licenses/by/4.0/).
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orldwide,  hepatitis  B  virus  (HBV),  hepatitis  C  virus  (HCV),
nd  human  immunodeﬁciency  virus  (HIV)  are  major  health
roblems.  Among  the  2  billion  people  infected  with  HBV
orldwide,  more  than  350  million  suffer  from  chronic  HBV
nfection.1,2 The  prevalence  of  HCV  infection  is  reported
o  be  2.3%--3%  (130--170  million  people),  of  which  80%
evelop  chronic  infection.3,4 Additionally,  WHO  reported
hat  2  million  people  were  infected  with  HIV  and  that  there
ere  1.2  million  deaths  related  to  AIDS  in  2014.5
Healthcare  workers  (HCWs)  are  at  risk  of  transmitting
lood--borne  viruses,  and  surgeons  have  a  higher  risk  of
xposure  to  blood  and  higher  rates  of  percutaneous  injury
han  other  healthcare  workers.6--8 It  is  estimated  that  16,000
CV;  66,000  HBV  and  1000  HIV  infections  have  occurred
orldwide  in  healthcare  workers  in  2000  as  a  result  of
ccupational  exposure  to  percutaneous  injury.8 Transmission
f  blood--borne  pathogens  can  occur  via  percutaneous  and
ucocutaneous  routes,  and  sometimes  via  exposure  to  other
ody  ﬂuids.8,9
Septoplasty  is  among  the  3  most  commonly  performed
tolaryngological  surgeries  worldwide.10,11 It  can  be  per-
ormed  under  general  or  local  anesthesia.12--14 The  nose
- and  in  particular  the  septum  --  is  a  vascular  organ  and
urgeons  commonly  encounter  bleeding  at  some  point  dur-
ng  septoplasty.  Moreover,  surgeons  generally  use  sutures  to
tabilize  the  septum,  to  stabilize  the  perichondrium  (using
ransﬁxion  sutures)  so  that  nasal  packing  is  unnecessary,  to
revent  such  complications  as  hematoma  and  bleeding,  and
r
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ho  close  any  septal  mucosa  tears.15,16 Turbinates  are  also
ascular  organs  and  turbinate  surgery  performed  with  sep-
al  surgery  further  increases  bleeding.17,18 These  factors  are
ssociated  with  surgeon  exposure  to  patient  blood  and/or
ecretions,  which  consequently  increases  the  risk  of  blood
orne  virus  transmission,  especially  HBV,  HCV,  and  HIV.19,20
At  our  clinic  preoperative  serological  testing  for  HBV,  HCV
nd  HIV  is  performed  in  every  adult  patient  in  which  elec-
ive  surgery  under  general  anesthesia  is  indicated,  but  not
n  patients  undergoing  elective  surgery  under  local  anesthe-
ia,  including  septoplasty.  The  aim  of  the  present  study  was
o  determine  the  seroprevalence  of  HBsAg,  anti-HCV,  and
nti-HIV  in  patients  undergoing  septoplasty  with  and  without
urbinate  surgery,  and  to  determine  if  preoperative  testing
or  HBV,  HCV,  and  HIV  should  also  be  performed  in  patients
ndergoing  septoplasty  with  and  without  turbinate  surgery
nder  local  anesthesia  as  an  additional  precaution  to  avoid
xposure  to  patient  blood  and  secretions  during  surgery.
ethods
his  study  included  3731  patients  that  underwent  septo-
lasty  with  and  without  turbinate  surgery  between  January
005  and  July  2015.  HBsAg,  anti-HCV,  and  anti-HIV  seropos-
tivity  in  patients  admitted  to  the  Otolaryngology  Clinic  for
eptoplasty  with  and  without  turbinate  surgery  was  ret-
ospectively  analyzed.  Preoperative  blood  samples  were
nalyzed  by  our  hospital’s  microbiology  department.  Patient
ge,  gender,  type  of  surgery,  and  serological  data  and
ematological  counts  were  recorded.  The  patients  who  had
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Seroprevalence  in  septoplasty  
additional  sinonasal  symptoms  and  whose  CT  scan  revealed
sinonasal  disease  had  endoscopic  sinus  surgery  in  addition
to  septoplasty  and  thus  were  excluded  from  the  study.
The  study  protocol  was  approved  by  the  local  Ethics
Committee  (18/12/2015-742),  and  was  conducted  in  accor-
dance  with  the  Declaration  of  Helsinki.  Data  frequency  and
mean  ±  SD  were  analyzed.
Statistical  analysis
Statistical  analysis  was  performed  using  SPSS  v.16.0  for  Win-
dows  (SPSS,  Inc.,  Chicago  IL).  Descriptive  statistics  are  given
with  each  value’s  Standard  Deviation  (SD).  The  normal-
ity  of  the  distribution  of  data  was  determined  using  the
Kolmogorov--Smirnov  test.  None  of  the  data  were  normally
distributed.  Gender  differences  in  age,  and  HBsAg,  anti-
HCV,  and  anti-HIV  seropositivity  were  analyzed  using  the
Mann--Whitney  U  test.  The  level  of  statistical  signiﬁcance
was  set  at  p  <  0.05.
Results
In  total,  3731  patients  underwent  septoplasty  in  the  oto-
laryngology  department  between  1  January  2005  and  31
December  2015.  Among  the  patients,  3241  underwent
surgery  with  general  anesthesia,  versus  490  with  local  anes-
thesia.  Preoperative  serological  data  were  available  only  for
patients  that  received  general  anesthesia;  thusly,  all  anal-
yses  were  performed  with  these  3241  patients’  data.  Mean
age  of  the  patients  was  36  years  (range:  11--81  years).  In
total,  117  (3.6%)  patients  were  positive  for  HBsAg,  12  (0.3%)
were  positive  for  anti-HCV,  and  7  (0.2%)  were  positive  for
anti-HIV.  All  7  patients  that  were  anti-HIV  positive  were
referred  for  further  conﬁrmation.  Among  the  patients,  11
were  aged  <  18  years,  all  of  which  were  negative  for  HBsAg,
anti-HCV,  anti-HIV.
Among  the  patients,  941  were  female  and  2300  were
male.  In  all,  2%  of  the  female  patients  (23/941)  were  positive
for  HBsAg,  versus  4%  of  the  males  (94/2300).  The  HBsAg  pos-
itivity  rate  was  signiﬁcantly  higher  in  males  (Mann--Whitney
U  test,  p  =  0.023).  In  total,  0.31%  of  the  female  patients
(3/941)  and  0.39%  of  the  male  patients  (9/2300)  were  pos-
itive  for  anti-HCV.  All  7  patients  that  were  positive  for
anti-HIV  were  male.  The  anti-HIV  positivity  rate  was  0.3%
considering  only  the  male  patients.  The  anti-HCV  and  anti-
HIV  positivity  rates  did  not  differ  signiﬁcantly  between
genders.  Serological  ﬁndings  are  summarized  in  the  Table  1.
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Table  1  Serological  data  for  HBsAg,  anti-HCV,  and  anti-HIV.
Total  Females  (n  =  9
n  %  n  %  
HBsAg  117  3.6  23  2
Anti-HCV  12  0.3  3  0
Anti-HIV 7  0.2  0  0
* p < 0.05 resembles statistical signiﬁcance. PRESS
3
No  alteration  or  correlation  was  found  between  the
ematological  counting  (Complete  Blood  Count)  and  the  pos-
tive  patients.
iscussion
BV,  HCV,  and  HIV  are  important  healthcare  problems  world-
ide.  Surgeons  have  a  higher  risk  of  exposure  to  blood  and
igher  rates  of  percutaneous  injury  than  the  other  health-
are  workers.6--8 and  the  signiﬁcant  rates  of  morbidity  and
ortality  due  to  these  viruses  suggest  surgeons  should  use  all
recautions  possible  to  avoid  exposure  to  patient  blood  and
ecretions  during  surgery.  Percutaneous  injury  occurs  during
any  surgical  procedures,  varying  in  frequency  with  surgical
pecialty,  and  the  75%  of  blood--borne  pathogen  exposure
ccurs  during  surgery.20,21 It  was  reported  that  5.5%  of
ercutaneous  injuries  occur  in  otolaryngological  practice.21
he  suture  needle  was  reported  to  be  the  instrument
ost  associated  with  percutaneous  injury  and  exposure  to
lood--borne  pathogens,  accounting  for  50%  of  all  surgical
njuries,  followed  by  sharp  instruments  (34%)  --  primarily  the
calpel  blade  (6.9%);  the  suture  needle  and  scalpel  blade
re  the  2  most  commonly  used  surgical  instruments  dur-
ng  septoplasty.20,21 Incision,  suturing,  wound  closure,  and
ncreased  bleeding  are  all  associated  with  surgeon  exposure
o  blood  and  secretions.20,21
It  was  reported  that  vaccination  against  HBV,  use  of  pro-
ective  glasses  and  gloves,  double  gloving,  and  blunt  suture
eedles  are  the  precautions  necessary  to  protect  against
lood  and  body  ﬂuid  exposure.7,21--24 Whether  or  not  pre-
perative  testing  of  patients  for  HBV,  HCV,  and  HIV  can
urther  decrease  the  risk  of  transmission  remains  unclear;
n  countries  with  low  infection  rates,  preoperative  testing  is
ot  common  because  it  is  not  thought  to  be  cost-effective,
hereas  in  countries  with  high  infection  rates  it  is  strongly
ecommend  that  preoperative  testing  be  performed.23,25
ransmission  of  infections  via  blood  occurs  at  a  higher  rate
n  developing  countries  than  in  developed  countries,  and
ccupational  blood  exposure  is  of  great  concern  in  devel-
ping  countries.19 Turkey  is  a  developing  country  in  which
he  seropositivity  rates  were  reported  to  be  0.52%--4.19%
or  HBsAg,  0.1%--1%  for  anti-HCV,  and  0%--0.1%  for  anti-HIV,
nd  the  present  seroprevalence  ﬁndings  of  the  current  study
re  similar  to  those  reported  earlier  for  Turkey.26--28 Turkey  is
n  intermediate-endemic  region  for  HBV  and  a  low-endemic
egion  for  HCV.4,29--32 Moreover,  HIV/AIDS  is  currently  con-
idered  to  be  an  emerging  disease  in  Turkey.33 As  such,  at
ur  surgical  department  we  request  preoperative  serolog-
cal  testing  including  HBsAg,  anti-HCV,  and  anti-HIV,  in  all
atients  undergoing  surgery  under  general  anesthesia.
41)  Males  (n  =  2300)  p
n  %
 94  4  0.023*
.31  9  0.39  0.758
 7  0.3  0.09
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The  preoperative  prevalence  of  HBV  in  the  present
tudy’s  septoplasty  patients  was  signiﬁcantly  higher  in  males
4%)  than  in  females  (2%),  as  previously  reported,  which
e  think  could  be  due  greater  social  mobility  and  free-
om  among  males  in  developing  countries,  especially  in  rural
reas,  making  the  male  population  more  prone  to  contract-
ng  the  infection34,35;  however,  there  are  other  studies  from
eveloping  countries  showing  higher  rates  of  infection  in
emales.36
Our  department  frequently  performs  septoplasty;  3731
atients  underwent  the  procedure  with  and  without
urbinate  surgery  between  2005  and  2015,  of  which  3241
eceived  general  anesthesia  and  490  received  local  anesthe-
ia.  Local  anesthesia  is  a  safe  and  cost-effective  technique
or  sinonasal  surgery  in  selected  patients  when  pain  can  be
revented  and/or  treated  during  surgery.12,37,38 Our  depart-
ent  generally  uses  general  anesthesia  during  septoplasty
3241  of  3731  patients)  and  all  patients  undergoing  sep-
oplasty  under  general  anesthesia  undergo  preoperative
erological  testing,  including  HBsAg,  anti-HCV,  and  anti-HIV;
owever,  serological  testing  is  not  performed  in  our  patients
ndergoing  septoplasty  under  local  anesthesia.  Local  anes-
hesia  is  associated  with  less  bleeding  during  septoplasty
han  general  anesthesia37,38;  however,  bleeding  can  still  be
 problem  for  some  patients  under  local  anesthesia.  Our
atients  that  receive  local  anesthesia  generally  have  a  high
isk  for  general  anesthesia,  including  hypertensive  patients
nd  patients  that  use  blood-thinners  for  cardiac  disorders.
hese  patients  have  a  tendency  for  bleeding  even  under
ocal  anesthesia,  putting  the  surgeon  at  risk  of  exposure
o  blood.  Additionally,  although  local  anesthetic  agents  are
ffective  pain  relievers,  it  is  reported  that  not  all  patients
re  satisﬁed  with  the  pain  medication  they  get  from  local
nesthesia.12 Patients  that  are  sensitive  to  pain  tend  to  make
harp  movements  in  response  to  pain  during  surgery,  jeop-
rdizing  positioning  of  the  scalpel  blade  and  sutures.14,39
oreover  experiencing  pain  increases  blood  pressure,  mak-
ng  patients  more  prone  to  bleeding.  Turbinate  surgery  also
ncreases  the  risk  of  bleeding.  All  of  these  factors  also  are
igniﬁcant  risk  factors  for  surgeon  exposure  to  blood  and
ercutaneous  injury  during  septoplasty  under  local  anesthe-
ia,  which  suggests  that  preoperative  serological  testing  in
atients  receiving  local  anesthesia  could  be  routine.
We  obtain  the  CT  scan  if  the  patient  reports  any  symp-
oms  related  to  sinus  disorders.  Of  the  patients  who  we
btained  CT  scan,  the  patients  who  had  sinus  disease  were
xcluded  from  the  study  and  had  endoscopic  sinus  surgery
erformed  in  addition  to  septoplasty.  We  wanted  to  exclude
hese  because  we  only  wanted  to  include  the  most  widely
erformed  procedure  (septoplasty)  and  make  the  surgeons
ware  that  although  it  is  commonly  performed  and  a  rela-
ively  easy  and  straightforward  surgery,  it  should  be  kept  in
ind  that  even  the  most  common  and  basic  surgical  proce-
ure  puts  the  surgeon  under  risk  of  transmitting  blood--borne
athogens.  When  thinking  about  the  complications  of  sep-
oplasty  or  any  surgery,  transmission  of  the  infection  should
lways  be  kept  in  mind.
As mentioned  above,  preoperative  serological  testing,
ncluding  HBsAg,  anti-HCV,  and  anti-HIV,  is  performed  in  all
f  our  patients  undergoing  surgery  under  general  anesthe-
ia.  In  a  developing  country  with  a  high  prevalence  of  these
iruses,  such  testing  alerts  surgeons,  nurses,  and  the  entire
s
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urgical  team  to  the  need  for  extra  caution  during  surgery.  In
ddition,  preoperative  serological  testing  facilitates  inform-
ng  our  patients  that  are  unaware  of  their  seropositivity
nd  early  detection  of  infection  in  patients  in  which  the
ssociated  diseases  would  otherwise  go  undetected,  which
elps  limit  the  spread  of  virus  in  the  community.  The
resent  study’s  seropositive  patients  were  referred  for  fur-
her  investigation  and  were  encouraged  to  take  all  necessary
recautions  to  prevent  transmission  to  other  individuals.
hese  precautions  are  especially  important,  as  worldwide
 high  proportion  of  occupationally  acquired  HCV,  HBV,  and
IV  infections  occur  in  developing  countries  such  as  Turkey,
n  which  healthcare  workers  are  exposed  to  a  patient  popu-
ation  with  a  higher  prevalence  of  blood--borne  viruses  than
n  developed  countries.19
None  of  the  7  patients  who  were  positive  for  anti-HIV
ere  aware  of  their  disease  before  the  surgery.  Of  the  12
atients  that  were  anti-HCV  positive,  only  one  patient  was
ware  of  his  results  before  the  surgery.  Of  the  117  patients
hat  were  HbS  Ag  positive,  32  patients  were  aware  of  their
esults  before  their  surgery.  These  numbers  may  be  somehow
nreliable,  as  these  diseases  can  be  sexually  transmitted
nd  the  people  who  know  they  have  the  disease  (especially
IV)  may  be  reluctant  to  express  that  they  have  an  infec-
ious  disease.  This  is  important  especially  in  conservative
ountries  where  people  who  have  these  diseases  (especially
IV  and  HCV)  might  be  excluded  from  the  society.  It  is  a  sur-
eon’s  most  important  responsibility  to  respect  the  patient
onﬁdentiality  and  to  reassure  the  patient  that  his  or  her
esults  will  be  kept  conﬁdential.  Other  than  that,  we  have
ad  patients  who  were  reluctant  to  inform  us  about  their
isease  before  their  blood  work  was  positive  for  infection,
hich  was  mainly  because  they  thought  their  disease  would
esult  in  cancelation  of  their  surgery.  Thus,  the  surgeon  must
nderstand  the  patients  concerns  and  address  any  questions
n  their  mind  accordingly.  Also,  we  had  patients  with  low
ocioeconomic  status  who  already  were  diagnosed  in  other
laces  before  we  obtained  blood  tests  from  them.  They  were
old  that  they  had  the  disease  in  the  place  they  were  diag-
osed,  but  failed  to  understand  or  did  not  pay  attention  to
t,  thus  did  not  inform  us  about  this.  Thus,  obtaining  these
lood  works  can  be  crucial  in  increasing  patient  awareness,
specially  in  countries  of  low  socioeconomic  status.  There
ay  be  many  other  reasons  for  the  patients  to  be  reluctant
o  tell  a surgeon  that  they  have  to  the  disease.  For  these
easons  we  obtain  these  blood  work  on  a  routine  basis  from
ll  our  patients  who  we  perform  surgery.
For  patients  undergoing  septoplasty  under  local  anes-
hesia,  it  might  also  be  useful  to  perform  preoperative
erological  testing,  as  septoplasty  is  also  associated  with
he  risk  of  contamination.  It  was  reported  that  Turkish
ealthcare  workers  in  a  hospital  setting  have  a high  risk  of
ercutaneous  injury/mucosal  exposure,  but  overall  aware-
ess  of  such  risk  is  low.40 Although  the  occupational  risk  to
ealthcare  workers  is  lower  in  Turkey  than  in  some  other
eveloping  countries,40--42 studies  show  that  there  is  a  high
ncidence  of  the  exposure  to  blood  borne  pathogens  in  Turk-
sh  HCWs,  as  compared  to  developed  countries.40,42--45 Some
tudies  indicate  that  routine  serological  testing  is  not  neces-
ary  for  all  preoperative  patients,  but  should  be  performed
n  patients  with  risk  factors.23 This  approach  could  be  feasi-
le  in  low  prevalence  countries,  but  not  in  Turkey,  which
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has  higher  prevalences.  Furthermore,  overall  awareness
of  percutaneous  and  mucocutaneous  injury  among  Turk-
ish  healthcare  workers  is  low.40 Educational  programs  for
increasing  awareness  of  the  risk  in  Turkish  hospitals  is  of
utmost  importance  and  when  combined  with  serological
testing,  such  programs  could  be  more  effective  and  fur-
ther  increase  awareness.  To  the  best  of  our  knowledge  the
present  study  is  the  ﬁrst  to  assess  the  prevalence  of  HBV,
HCV,  and  HIV  infection  in  patients  undergoing  septoplasty.
Also,  our  study  includes  a  large  patient  population.
Conclusion
Septoplasty  with  and  without  turbinate  surgery  is  associated
with  the  risk  of  transmission  of  blood--borne  virus  transmis-
sion  to  surgeons,  whether  performed  under  local  or  general
anesthesia.  The  present  ﬁndings  indicate  that  education
of  healthcare  workers  combined  with  routine  preoperative
serological  testing  in  patients  undergoing  septoplasty  under
general  and  local  anesthesia  could  further  increase  patient
and  healthcare  worker  awareness,  and  decrease  contamina-
tion  rates.
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